Arabic version: توجيهات اللقاحات في الولايات المتحدة تواجه عدم اليقين تحت تغييرات إدارة ترامب
The landscape of vaccine recommendations in the United States has been thrown into disarray following significant changes initiated by the Trump administration. Several vaccines, including those for Covid-19 and flu, have lost their recommendations from the Centers for Disease Control and Prevention (CDC) due to a court ruling that halted the actions of the Advisory Committee on Immunization Practices (ACIP).
According to The Guardian, access to existing vaccines – and the future development of new vaccines – has been increasingly called into question under the second Trump administration, as the now-halted Advisory Committee on Immunization Practices (ACIP) made controversial recommendations and health officials made unilateral changes to routine vaccines, with long-term and global implications. Recommendations for the current annual flu and Covid shots no longer exist, and the recommendation for a new shot to protect babies against RSV (respiratory syncytial virus) is also on hold, leading to uncertainty about potential updates in the coming months.
The situation escalated after a federal judge, Brian Murphy, issued a stay on changes made by the Trump administration, following a lawsuit from the American Academy of Pediatrics (AAP). This ruling has effectively overturned decisions made by ACIP and health officials, creating a chaotic environment for vaccine access and recommendations.
Health experts warn that delays in vaccine updates could lead to public health risks, particularly as respiratory virus seasons approach. Without a functioning ACIP, no new vaccine recommendations can be made, and the lack of a confirmed CDC director complicates the situation further. The current administration has the legal authority to make recommendations, but the ongoing legal challenges may obstruct these efforts.
As states grapple with the changes, about 29 states and Washington DC have moved to decouple their vaccination processes from the ACIP, while others remain tied to the now-controversial recommendations. This inconsistency could create barriers for residents in accessing necessary vaccines, intensifying public confusion and mistrust regarding vaccine safety and efficacy.
